ArticleDiscover oncology2025

Efficacy and safety of PD-1 inhibitors combined with anti-angiogenic agents in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis.

Jingjing Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.